The object
Daniel Anderson co-invented lipid-nanoparticle formulations and delivery methods that package nucleic-acid medicines for entry into cells. MIT’s 2025 report identifies Anderson as senior author of a new low-dose mRNA-delivery particle, while patent records name him on current lipid-particle inventions.
01
What Daniel did
Co-invented lipid-nanoparticle formulations and delivery methods for nucleic-acid medicines.
02
Why it matters
Lipid nanoparticles made fragile nucleic-acid payloads deliverable as manufactured medicines, helping establish the mRNA therapeutic and vaccine hardware-material platform.
03
Living-status check
MIT published Anderson’s active mRNA-delivery work on 7 November 2025; 2025 patent records also name him on lipid-particle inventions.